RPL12P40

Across TCGA pan-cancer cohorts, RPL12P40 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RPL12P40 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RPL12P40 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL12P40 expression acts as an unfavorable survival marker, although some lineages such as LUAD and COAD show a favorable association.

ESCA, HNSC, and TGCT are the cancer types where RPL12P40 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
HNSC	DFS	Tertile	All	0.272	0.560	.010	33	view →
TGCT	DFS	Tertile	All	0.431	0.845	.007	18	view →
UCS	OS	Tertile	All	0.183	0.593	.011	18	view →
ACC	DFS	Tertile	II,III,IV	0.242	0.724	.034	18	view →
STAD	OS	Tertile	III,IV	0.498	0.658	.024	15	view →
SARC	OS	Tertile	All	0.629	0.842	.039	12	view →
LUAD	DFS	Tertile	All	0.791	0.332	.030	9	view →
COAD	DFS	Tertile	All	0.879	0.498	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RPL12P40–ESCA (OS)

Open the ESCA breakdown →